Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.3 USD | +0.85% | -3.54% | -0.05% |
May. 14 | Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM | |
Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
Evolution of the average Target Price on Revvity, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Revvity, Inc.
TD Cowen | |
JPMorgan Chase | |
Baird | |
Bernstein | |
Nephron Research | |
KeyBanc Capital Markets | |
Raymond James | |
BofA Securities | |
Barclays | |
UBS | |
Evercore ISI | |
Wells Fargo Securities | |
Goldman Sachs | |
Citigroup | |
Stifel Nicolaus | |
Cowen | |
Credit Suisse | |
BMO Capital | |
Wolfe Research |
EPS Revisions
- Stock Market
- Equities
- RVTY Stock
- Consensus Revvity, Inc.